Rare diseases
Investigational molecules
Locations
Via Luigi Polacchi 11, 66100 Chieti, Italy
Università degli studi Gabriele D’Annunzio Chieti-Pescara Centro di Studi e tecnologie avanzate in Chieti, Italy specialises in clinical trials of conditions such as Dermatitis atopic, Obesity, Type 2 diabetes mellitus, Partial seizures, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Neurogenic Orthostatic Hypotension (nOH), a condition characterized by a significant drop in blood pressure upon standing, often associated with neurological disorders such as Multiple System Atrophy (MSA). The center's research focuses on innovative therapeutic approaches to manage and alleviate the symptoms of nOH, enhancing the quality of life for affected individuals.
Through rigorous clinical trials, the center evaluates the effectiveness and sustainability of novel treatments, contributing to the development of advanced therapeutic strategies for nOH. This research not only aims to improve patient outcomes but also to deepen the understanding of the underlying mechanisms of this complex condition.
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
ItalyItalyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
ItalyA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
ItalyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
ItalyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
ItalyLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
ItalyA Phase 3 Study of Once‑Monthly PF‑08653944 vs Placebo for Weight Loss in Adults with Overweight or Obesity
ItalySafety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression
ItalyItalyA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
ItalyA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
